Formoterol 20 mcg + Budesonide per 2 ml respule Nebulizer Respule (Budemide-F)

Formoterol 20 mcg + Budesonide Respules — Combination ICS + LABA Nebulizer Therapy

Budemide-F Respules — Formoterol 20 mcg + Budesonide per 2 ml respule from Trumac Healthcare PCD Pharma Franchise India

Composition Formoterol 20 mcg + Budesonide per 2 ml respule
Dosage Form Nebulizer Respule
Pack Type Respule Pack
Pack Size 5 x 4 Respules (20)
MRP ₹ 1200
Therapy G.P. + Gynaecology / Respiratory — Inhaled Corticosteroid + Long-Acting Beta-2 Agonist (ICS+LABA)
Storage Store below 25 °C, protected from light. Use immediately after opening foil sachet.

WhatsApp EnquiryCall: +919041677932

For chemists, distributors and doctors: Budemide-F (formoterol 20 mcg + budesonide per 2 ml respule nebulizer respule) is available from Trumac Healthcare on a PCD franchise with monopoly rights for your district, and as wholesale stock for licensed distributors. No franchise fee; first order from ₹25,000 – work out your margin with the PTR / PTS calculator.

WhatsApp for price list & availability

About Budemide-F Respules

Budemide-F Respules combine the long-acting beta-2 agonist Formoterol 20 mcg with the inhaled corticosteroid Budesonide in a single 2 ml nebuliser respule. It is used for the maintenance therapy of moderate-to-severe persistent asthma and COPD in adults — where combined ICS + LABA therapy provides better symptom control than either component alone.

Formoterol is a fast-onset (within 1–3 minutes) and long-duration (12-hour) beta-2 agonist that produces sustained bronchodilation. Budesonide simultaneously suppresses airway inflammation that drives bronchial hyperreactivity. The combination is supported by GINA guidelines as step-up therapy from ICS monotherapy in moderate asthma.

Budemide-F is made for Trumac Healthcare at WHO-GMP certified partner units. Available for monopoly-based PCD pharma franchise and third-party manufacturing — a high-value respiratory SKU.

Budemide-F का उपयोग (हिंदी में): दमा और COPD की इनहेलर दवा। सभी Trumac दवाओं के उपयोग हिंदी और अंग्रेज़ी में – Trumac Healthcare tablet uses A–Z। दवा हमेशा डॉक्टर की सलाह से ही लें।

Indications

  • Maintenance therapy of moderate-to-severe persistent asthma
  • COPD with frequent exacerbations
  • Asthma inadequately controlled on ICS monotherapy
  • Step-up therapy when short-acting bronchodilator use is frequent

Mechanism of Action

Formoterol selectively activates β2-adrenergic receptors on airway smooth muscle, raising cAMP and producing sustained bronchodilation lasting 12 hours. Budesonide binds glucocorticoid receptors in airway tissue, suppressing pro-inflammatory gene transcription and reducing airway hyperreactivity. The combination targets both bronchospasm and underlying inflammation.

Dosage & Administration

Adults: 1 respule by nebulisation twice daily. Rinse mouth after each use to prevent oral candidiasis. To be prescribed by a physician.

Side Effects

Tremor, palpitations, headache (Formoterol). Oral candidiasis, dysphonia, throat irritation (Budesonide). Rare: paradoxical bronchospasm, hypokalaemia with high doses.

Contraindications & Precautions

Hypersensitivity to either component. Tachyarrhythmias. Severe cardiovascular disease (caution). Untreated bacterial respiratory infection. Children < 12 years for this strength.

Storage

Store below 25 °C, protected from light. Use immediately after opening foil sachet.

Part of our PCD pharma franchise range, available on a monopoly basis – see the gynae PCD pharma franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.

PCD Pharma Franchise & Third-Party Manufacturing
Budemide-F Respules is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Budemide-F Respules used for?

Budemide-F Respules combine Formoterol and Budesonide for maintenance therapy of moderate-to-severe asthma and COPD requiring combined ICS + LABA therapy.

How does Budemide-F differ from Budemide-0.5?

Budemide-0.5 is Budesonide alone (anti-inflammatory). Budemide-F adds Formoterol, a long-acting bronchodilator — used when asthma is inadequately controlled on ICS alone.

Is Budemide-F available for PCD pharma franchise?

Yes, Trumac Healthcare offers Budemide-F on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Budemide-F be stored?

Store below 25 °C, protected from light. Use immediately after opening foil sachet.

Is Budemide-F WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.